Franklin Templeton ETF Trust - Franklin Genomic Advancements ETF (United States) is an exchange-traded fund (ETF), with assets under management totaling $22.61 M.
Over the past 12 months, Franklin Templeton ETF Trust - Franklin Genomic Advancements ETF recorded a return of 34.90%, with its price trading between $25.43 and $38.10 during the same period.
The ETF is traded under the ticker HELX.